Skip to main content
    I

    InflaRx N.V. (IFRX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.15
    -0.03 (-2.54%)

    Market Cap: $172.42M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    InflaRx N.V. (IFRX) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    InflaRx (IFRX) has a market cap of $172.42M. Its share count is up 116.35% from a year earlier. Revenue fell 154.00% over the last 12 months from the 12 months before.

    Total Valuation

    Market Cap$172.42M
    Latest price (Nov 17, 2026)$1.15

    Key Dates

    The next earnings report is expected on Mar 17, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 17, 2027 (expected)
    Last Earnings DateNov 3, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 25.25% in the quarter ended Sep 30, 2026 and grew 58.20% a year over 2 years.

    Shares Outstanding147.37M
    Shares Change (YoY)+116.35%
    Shares Change (QoQ)+25.25%
    Share Count Growth (2Y CAGR)+58.20%

    Valuation Ratios

    P/B Ratio1.0x
    P/TBV Ratio1.0x

    Price Statistics

    The stock is down 14.81% over 52 weeks and trades 30.30% below its 50-day average.

    Beta (1Y)1.51
    52-Week Change-14.81%
    1-Month Change-20.69%
    3-Month Change-45.75%
    6-Month Change-51.48%
    5-Year Change-60.85%
    Total Return (1Y)-14.81%
    Total Return (3Y CAGR)-8.27%
    Total Return (5Y CAGR)-24.68%
    Return vs SPY (1Y)-21.01%
    Max Drawdown (1Y)-58.03%
    Max Drawdown (3Y)-72.94%
    Sharpe Ratio (1Y)-0.12
    Correlation with SPY (1Y)0.25
    50-Day Average$1.65
    200-Day Average$1.66
    52-Week Range$0.80 to $2.95
    RSI (14 Days)30.8
    Average Volume (20 Days)1.05M

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 7.26x current liabilities.

    Current Ratio7.26x
    Quick Ratio7.26x
    Interest Coverage-491.74x

    Returns and Efficiency

    Return on equity is -20.76% over the last 12 months, against a 5-year average of -60.63%.

    Return on Equity (ROE)-20.76%
    Return on Assets (ROA)-18.54%
    Return on Capital Employed (ROCE)-20.23%
    ROE (5Y Average)-60.63%
    ROA (5Y Average)-48.81%
    ROIC (5Y Average)-59.71%
    Receivables Turnover0.02x

    Scores

    IFRX has an Altman Z-Score of 1.94, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Altman Z-Score1.94
    Altman Z ZoneGrey
    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was EUR -33.93K over the last 12 months.

    RevenueEUR -33.93K
    Revenue Growth (YoY)-154.00%
    Gross ProfitEUR -5.07M
    Operating IncomeEUR -32.66M
    Pretax IncomeEUR -29.32M
    Net IncomeEUR -29.32M
    EBITDAEUR -28.91M
    EBITEUR -29.26M

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 89.33% of the EUR 161.32M in total assets.

    Working CapitalEUR 104.33M
    Shareholder EquityEUR 144.10M
    Tangible Book ValueEUR 143.98M
    Total AssetsEUR 161.32M
    Total LiabilitiesEUR 17.22M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After EUR 103.47K of capital spending, operating cash flow left EUR -18.92M of free cash flow.

    Operating Cash FlowEUR -18.82M
    Capital ExpendituresEUR 103.47K
    Free Cash FlowEUR -18.92M
    Depreciation and AmortizationEUR 355.80K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About IFRX

    What is IFRX's market cap?

    InflaRx has a market cap of $172.42M.

    How many shares of IFRX are outstanding?

    InflaRx has 147.37M shares outstanding. The count is up 116.35% from a year earlier.

    Does IFRX pay a dividend?

    No. InflaRx does not pay a dividend.